Pui Chun Suen
Corporate Officer/Principal bei The Hong Kong Institute of Chartered Secretaries
Profil
Pui Chun Suen is currently an Associate Member at The Hong Kong Institute of Chartered Secretaries.
Previously, she worked as a Secretary at AG Consultants from 2010 to 2011, and as a Manager-Corporate Services at Vistra Corporate Services (HK) Ltd.
from 2014 to 2022.
She also served as a Joint Secretary at Powerlong Real Estate Holdings Ltd., Powerlong Commercial Management Holdings Ltd., and Ocumension Therapeutics from 2020 to 2022.
Additionally, she was a Joint Secretary at Shanghai Ark Biopharmaceutical Co., Ltd., a Secretary at Akeso, Inc., and a Co-Secretary at Peijia Medical Ltd.
Ms. Suen received her undergraduate degree from City University of Hong Kong in 2000 and her graduate degree from The Open University of Hong Kong in 2019.
Aktive Positionen von Pui Chun Suen
| Unternehmen | Position | Beginn |
|---|---|---|
The Hong Kong Institute of Chartered Secretaries
 The Hong Kong Institute of Chartered Secretaries Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institute of Chartered Secretaries is an independent professional body that promotes the role of its members in formulating and implementing good governance policies. The private company is based in Hong Kong, Hong Kong. It also aims to develop the profession of chartered secretary and chartered governance professional in mainland China. The institute was established in 1949 as an association of members of the Chartered Governance Institute and gained local status in 1994. It has more than 6,000 members and 3,200 students. | Corporate Officer/Principal | 01.11.2019 |
Ehemalige bekannte Positionen von Pui Chun Suen
| Unternehmen | Position | Ende |
|---|---|---|
| POWERLONG REAL ESTATE HOLDINGS LIMITED | Corporate Secretary | 30.08.2022 |
| POWERLONG COMMERCIAL MANAGEMENT HOLDINGS LIMITED | Corporate Secretary | 30.08.2022 |
| AKESO, INC. | Corporate Secretary | 23.08.2022 |
| PEIJIA MEDICAL LIMITED | Corporate Secretary | 17.06.2022 |
| OCUMENSION THERAPEUTICS | Corporate Secretary | 15.06.2022 |
Ausbildung von Pui Chun Suen
| City University of Hong Kong | Undergraduate Degree |
| The Open University of Hong Kong | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| POWERLONG REAL ESTATE HOLDINGS LIMITED | Finance |
| POWERLONG COMMERCIAL MANAGEMENT HOLDINGS LIMITED | Finance |
| OCUMENSION THERAPEUTICS | Health Technology |
| AKESO, INC. | Health Technology |
| PEIJIA MEDICAL LIMITED | Health Technology |
| Private Unternehmen | 4 |
|---|---|
AG Consultants
 AG Consultants Hospital/Nursing ManagementHealth Services AG Consultants provides banking and financial services. The company is headquartered in Brooklyn, NY. | Health Services |
The Hong Kong Institute of Chartered Secretaries
The Hong Kong Institute of Chartered Secretaries Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institute of Chartered Secretaries is an independent professional body that promotes the role of its members in formulating and implementing good governance policies. The private company is based in Hong Kong, Hong Kong. It also aims to develop the profession of chartered secretary and chartered governance professional in mainland China. The institute was established in 1949 as an association of members of the Chartered Governance Institute and gained local status in 1994. It has more than 6,000 members and 3,200 students. | Commercial Services |
| Vistra Corporate Services (HK) Ltd. | |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
